6505--Fludrocortisone Acetate Tablets (VA-25-00047932)

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
36E79725R0023
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs National Acquisition Center is seeking to procure Fludrocortisone Acetate 0.1MG Tablets through Solicitation No. 36E79725R0023. The contract aims to establish a supply source for pharmaceutical products to be distributed through VA and Department of Defense Pharmaceutical Prime Vendor Programs. Offerors must submit pricing for a base year and four potential option years, with prices limited to two decimal places and including a 0.5% Cost Recovery Fee. Qualification requirements include providing a unique 11-digit National Drug Code (NDC) number and a Letter of Commitment from the manufacturer if the offeror is not the manufacturer itself. The solicitation will be evaluated on a lowest price technically acceptable basis, with proposals due by April 21, 2025, at 2:30 PM Central Time, and an anticipated contract effective date of March 28, 2025.

The solicitation is set aside for small businesses with a size standard of 1,300 employees. The estimated annual usage is 31,127 bottles, which will be distributed across VA, DoD, Bureau of Prisons, and Indian Health Service facilities. While no specific incumbent contractors are mentioned, the procurement targets pharmaceutical manufacturers capable of meeting FDA current Good Manufacturing Practices standards. The contract structure includes a base year with four one-year option periods, providing potential long-term procurement stability for the selected vendor. Performance will be managed through the Department of Veterans Affairs OPAL / National Acquisition Center located in Hines, Illinois, with the procurement falling under the Pharmaceutical Preparation Manufacturing (NAICS 325412) and Drugs and Biologicals (PSC 6505) categories.

Notice text

2 versions

Update #2 · Latest ·

This amendment extends the due date and time for offers. See document for details.

Update #1 ·

N/A

Files

File Type Posted
36E79725R0023 0001.docx DOCX document
36E79725R0023.docx DOCX document

Notice history

Notice Type Posted
6505--Fludrocortisone Acetate 0. 1MG Tablets Award Award Notice
This notice Latest solicitation Solicitation
6505--Fludrocortisone Acetate Tablets (VA-25-00047932) Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Sacubitril/Valsartan Tablets (VA-27-00014055) NAICS 325412 National Acquisition Center No set-aside
6505--Ramipril Capsules RFP NAICS 325412 National Acquisition Center No set-aside
6505--Latanoprost Ophthalmic Solution (VA-27-00006027) NAICS 325412 National Acquisition Center No set-aside
6505--FY27 Lenalidomide BPA Department of Veterans Affairs Participating VA Medical Centers · NAICS 325412 Veterans Integrated Service Network 22 No set-aside
6505--VA Long Beach Pylarify NAICS 325412 Veterans Integrated Service Network 22 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors